Comparison

BTSA1 European Partner

Item no. HY-123054-50mg
Manufacturer MedChem Express
CASRN 314761-14-3
Amount 50 mg
Quantity options 100 mg 10mM/1mL 10 mg 25 mg 50 mg 5mg
Category
Type Inhibitors
Specific against other
Purity 99.49
Formula C21H14N6OS2
Citations [1]Reyna DE, et al. Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia. Cancer Cell. 2017 Oct 9;32(4):490-505.e10.
Smiles O=C(N(C1=NC(C2=CC=CC=C2)=CS1)N=C/3C4=CC=CC=C4)C3=N\NC5=NC=CS5
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 314761-14-3
Available
Product Description
BTSA1 is a potent, high affinity and orally active BAX activator with an IC50 of 250 nM and an EC50 of 144 nM. BTSA1 binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
430.51
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : 25 mg/mL (ultrasonic)
Target
Apoptosis; Bcl-2 Family
Manufacturers Target
Apoptosis; Bcl-2 Family
Isoform
Bax
Manufacturers Pathway
Apoptosis
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close